AIA
DGX icon

Affinity Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Affinity Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,575
Closed -$221K – 184
2023
Q2 		$221K Hold
1,575
– – 0.13% 182
2023
Q1 		$223K Hold
1,575
– – 0.12% 179
2022
Q4 		$246K Buy
+1,575
New +$226K 0.11% 175
2022
Q3 		– Sell
-1,575
Closed -$209K – 190
2022
Q2 		$209K Sell
1,575
-180
-10% -$24.5K 0.1% 186
2022
Q1 		$240K Buy
1,755
+198
+13% +$27.6K 0.1% 188
2021
Q4 		$269K Buy
+1,557
New +$237K 0.11% 169

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Affinity Investment Advisors's DGX Position: Q3 2023 in Review

Affinity Investment Advisors sold out of Quest Diagnostics (DGX) in Q3 2023, closing a stake of 1,575 shares — an estimated $221K sold.

Affinity Investment Advisors first reported a position in DGX in Q4 2021 and held it in 6 quarters. The position peaked at $269K in Q4 2021. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.

  • Affinity Investment Advisors reported no remaining Quest Diagnostics position as of Q3 2023 after selling out during the quarter.
  • Affinity Investment Advisors sold 1,575 Quest Diagnostics shares in Q3 2023, an estimated $221K.
  • Affinity Investment Advisors first reported a position in Quest Diagnostics in Q4 2021 and held it in 6 quarters.
  • Affinity Investment Advisors's Quest Diagnostics position peaked at $269K in Q4 2021.
  • 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.

Based on Affinity Investment Advisors's 13F filing for Q3 2023, filed 26 Oct 2023.